New Zealand markets closed

Corvus Pharmaceuticals, Inc. (CRVS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.7800-0.1300 (-6.81%)
At close: 04:00PM EDT
1.7784 -0.00 (-0.09%)
After hours: 04:17PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.9100
Bid1.7600 x 100
Ask1.8600 x 100
Day's range1.7800 - 1.9500
52-week range1.0500 - 3.1600
Avg. volume236,422
Market cap111.341M
Beta (5Y monthly)1.10
PE ratio (TTM)N/A
EPS (TTM)-0.5100
Earnings date06 Aug 2024 - 12 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est7.83
  • Simply Wall St.

    Corvus Pharmaceuticals, Inc.'s (NASDAQ:CRVS) stock price dropped 12% last week; retail investors would not be happy

    Key Insights Significant control over Corvus Pharmaceuticals by retail investors implies that the general public has...

  • GlobeNewswire

    Corvus Pharmaceuticals to Present at the Jefferies Global Health Conference

    BURLINGAME, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that Richard A. Miller, M.D., president and chief executive officer, and Jeffrey Arcara, chief business officer, will conduct one-on-one meetings with investors and present a corporate overview at the Jefferies Global Health Conference, which is being held in New York from June 5-7, 2024. The Company’s presentation will be on Wednesday, Jun

  • Insider Monkey

    13 Penny Stocks with Insider Buying in 2024

    In this article, we will take a detailed look at the 13 Penny Stocks with Insider Buying in 2024. If you want to skip our detailed analysis and see the top 5 stocks in this list, click 5 Penny Stocks with Insider Buying in 2024. Insider transactions have always drawn market attention as it’s now a well-known fact […]